Novavax Asked the FDA for Emergency Use Earlier This Year. What’s the Delay?

“It’s been far too long since Novavax has asked for authorization and I think the FDA has been slow-walking it,” said Lawrence Gostin, a Professor of Global Health Law at Georgetown University. 

Read the article here.